According to a newly published market research report by 24LifeSciences, global Amitriptyline Hydrochloride Tablets market was valued at USD 320 million in 2025 and is projected to reach USD 480 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 20262034. Amitriptyline Hydrochloride, a tricyclic antidepressant (TCA), is clinically proven for...

According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological...

According to a newly published market research report by 24LifeSciences, global Calcium Folinate for Injection market was valued at USD 587.2 million in 2023 and is projected to reach USD 825.6 million by 2030, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2024–2030. Calcium Folinate, also known as leucovorin calcium, is a critical folic acid...

The global Cardiac Cannula Market was valued at USD 271.9 million in 2025 and is projected to grow from USD 288.7 million in 2026 to USD 447.2 million by 2033, registering a CAGR of 6.5% from 2026 to 2033. North America accounted for the largest revenue share of 37.9% in 2025, driven by advanced cardiovascular healthcare infrastructure, high procedural volumes, and the widespread...

According to a newly published market research report by 24LifeSciences, global Hepatocellular Carcinoma Drugs market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Hepatocellular Carcinoma (HCC), the most common primary liver cancer accounting for 90% of...

 Hydrogen Peroxide Vapor (HPV) Decontamination System Market was valued at USD 686 million in 2024 and is projected to reach USD 937 million by 2031, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period. This steady growth reflects the increasing emphasis on contamination control across healthcare, pharmaceutical manufacturing, and research environments, where...

According to a newly published market research report by 24LifeSciences, global hypogonadism treatment market was valued at USD 3.54 billion in 2024 and is projected to reach USD 5.91 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 20252032. Hypogonadism, a condition characterized by inadequate gonadal function, results in insufficient...

According to a newly published market research report by 24LifeSciences, global physical therapy services market was valued at USD 45.2 billion in 2024 and is projected to reach USD 67.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025-2031. Physical therapy services, encompassing specialized treatments like orthopedic rehabilitation,...

Structural heart devices are transforming the treatment of complex cardiovascular diseases by offering minimally invasive alternatives to conventional open-heart surgeries. These devices are widely used to treat conditions such as aortic stenosis, mitral valve disorders, septal defects, and other structural abnormalities of the heart. The increasing burden of cardiovascular diseases (CVDs),...

 3D cardiac imaging market continues to demonstrate strong expansion within the healthcare and life sciences sector, supported by rapid technological innovation and rising cardiovascular disease prevalence worldwide. Valued at USD 4.94 billion in 2024, the market is projected to reach USD 8.67 billion by 2031, registering a compound annual growth rate (CAGR) of 8.6% during the forecast...